Integrilin is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Eptifibatide.
| Product ID | 0085-1136_0b07e9e2-08a4-4b8f-a3d5-81dfe25f2031 |
| NDC | 0085-1136 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Integrilin |
| Generic Name | Eptifibatide |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2014-08-18 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020718 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | EPTIFIBATIDE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1998-05-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020718 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1998-05-18 |
| Marketing Category | NDA |
| Application Number | NDA020718 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2014-08-18 |
| Marketing Category | NDA |
| Application Number | NDA020718 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-01-23 |
| Ingredient | Strength |
|---|---|
| EPTIFIBATIDE | .75 mg/mL |
| SPL SET ID: | bd14390c-f3a1-4f19-a9d0-f137abfcddc0 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0085-1136 | Integrilin | Eptifibatide |
| 0085-1177 | Integrilin | Eptifibatide |
| 0338-9558 | Eptifibatide | Eptifibatide |
| 0338-9559 | Eptifibatide | Eptifibatide |
| 0703-1165 | Eptifibatide | Eptifibatide |
| 14335-070 | Eptifibatide | eptifibatide |
| 14335-071 | Eptifibatide | eptifibatide |
| 16729-259 | EPTIFIBATIDE | Eptifibatide |
| 16729-260 | EPTIFIBATIDE | Eptifibatide |
| 17478-902 | Eptifibatide | Eptifibatide |
| 17478-903 | Eptifibatide | Eptifibatide |
| 25021-408 | eptifibatide | eptifibatide |
| 25021-409 | eptifibatide | eptifibatide |
| 52958-040 | Eptifibatide | Eptifibatide |
| 52958-402 | Eptifibatide | Eptifibatide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() INTEGRILIN 75009658 2234543 Live/Registered |
MILLENNIUM PHARMACEUTICALS, INC. 1995-10-11 |